Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,069 | 1,074 | 98.0% |
| Education | $319.91 | 6 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,956 | 209 | $0 (2024) |
| Janssen Biotech, Inc. | $2,713 | 213 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,335 | 81 | $0 (2024) |
| Galderma Laboratories, L.P. | $969.57 | 47 | $0 (2024) |
| GENZYME CORPORATION | $951.13 | 55 | $0 (2024) |
| Lilly USA, LLC | $921.96 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $849.28 | 61 | $0 (2023) |
| PFIZER INC. | $778.49 | 54 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $539.23 | 35 | $0 (2024) |
| UCB, Inc. | $530.29 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,865 | 248 | Janssen Biotech, Inc. ($907.95) |
| 2023 | $3,264 | 223 | Janssen Biotech, Inc. ($775.11) |
| 2022 | $2,704 | 238 | ABBVIE INC. ($659.40) |
| 2021 | $1,909 | 125 | AbbVie Inc. ($456.70) |
| 2020 | $1,367 | 90 | Janssen Biotech, Inc. ($194.31) |
| 2019 | $1,577 | 97 | AbbVie, Inc. ($262.25) |
| 2018 | $1,240 | 41 | Galderma Laboratories, L.P. ($505.48) |
| 2017 | $463.04 | 18 | Novartis Pharmaceuticals Corporation ($173.58) |
All Payment Transactions
1,080 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Immunology | ||||||
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $38.27 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $57.20 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.87 | General |
| Category: Immunology | ||||||
| 11/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,759 | 6,948 | $1.7M | $335,977 |
| 2022 | 28 | 3,504 | 6,594 | $1.6M | $317,221 |
| 2021 | 25 | 3,036 | 5,538 | $1.3M | $280,074 |
| 2020 | 25 | 2,994 | 5,761 | $951,815 | $268,380 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 632 | 864 | $256,608 | $52,122 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 396 | 530 | $222,600 | $44,889 | 20.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 497 | 611 | $206,518 | $39,923 | 19.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 344 | 417 | $157,626 | $34,871 | 22.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 131 | 142 | $143,562 | $32,801 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 505 | 702 | $156,546 | $25,164 | 16.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 86 | 107 | $60,134 | $13,757 | 22.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 390 | 2,435 | $56,005 | $12,936 | 23.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 196 | 319 | $53,592 | $12,891 | 24.1% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 11 | 149 | $58,259 | $12,590 | 21.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 84 | 97 | $78,861 | $9,578 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $42,804 | $7,749 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $31,726 | $5,922 | 18.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 50 | 53 | $49,131 | $5,903 | 12.0% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 18 | 19 | $21,147 | $4,750 | 22.5% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 20 | 20 | $20,620 | $4,681 | 22.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 70 | $13,020 | $2,987 | 22.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 22 | $13,068 | $2,795 | 21.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 12 | 12 | $10,536 | $2,482 | 23.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 33 | 37 | $11,248 | $1,755 | 15.6% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $13,424 | $1,568 | 11.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 16 | $9,152 | $1,133 | 12.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $4,998 | $1,051 | 21.0% |
| 69100 | Biopsy of ear | Office | 2023 | 19 | 19 | $6,099 | $901.75 | 14.8% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $5,731 | $709.39 | 12.4% |
About Dr. Amy Mcclung, MD
Dr. Amy Mcclung, MD is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1033372586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Mcclung, MD has received a total of $16,389 in payments from pharmaceutical and medical device companies, with $3,865 received in 2024. These payments were reported across 1,080 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($16,069).
As a Medicare-enrolled provider, Mcclung has provided services to 13,293 Medicare beneficiaries, totaling 24,841 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 07/04/2008
- Last Updated 07/21/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1033372586
Products in Payments
- DUPIXENT (Biological) $2,119
- TREMFYA (Drug) $2,074
- SKYRIZI (Biological) $1,407
- TALTZ (Drug) $921.96
- EUCRISA (Drug) $722.34
- RINVOQ (Biological) $648.26
- REMICADE (Biological) $566.64
- SOOLANTRA (Drug) $540.84
- COSENTYX (Biological) $526.18
- Sotyktu (Drug) $422.22
- ADBRY (Biological) $378.20
- VTAMA (Drug) $374.18
- Humira (Biological) $357.05
- Cimzia (Drug) $318.18
- OPZELURA (Drug) $284.65
- BOTOX COSMETIC (Biological) $228.43
- Bimzelx (Biological) $212.11
- ORACEA (Drug) $208.60
- ILUMYA (Biological) $205.26
- HUMIRA (Biological) $195.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608